En direct

Géraldine Guasch (CRCM) - Publication dans Nature Communications -

Nov 2018 British journal of cancer

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer.

Auteurs

Bertucci F, Finetti P, Simeone I, Hendrickx W, Wang E, Marincola FM, Viens P, Mamessier E, Ceccarelli M, Birnbaum D, Bedognetti D

Résumé

The immunologic constant of rejection (ICR) is a broad phenomenon of Th-1 immunity-mediated, tissue-specific destruction.

Lire l‘article